What is Gotu Kola?
Gotu Kola (Centella asiatica) is a creeping perennial plant native to tropical and subtropical regions of Asia, particularly Southeast Asia. Known as “Tigergras” in German and “Asiatic pennywort” in English, this herb has been used in traditional Ayurvedic and Traditional Chinese Medicine for thousands of years. In recent decades, it has gained traction in Western supplement markets as a potential support for vascular function, skin health, and cognitive performance.
The name “Gotu Kola” comes from Sinhalese (the language of Sri Lanka), where the plant has held cultural significance for centuries. Modern phytochemistry has identified several bioactive compounds in Gotu Kola, including triterpenes (asiaticoside, madecassoside, asiaticin), flavonoids, and polyphenols, which are thought to mediate many of its traditional uses.
Vascular and Circulatory Support
One of the most researched applications of Gotu Kola in modern science concerns venous function and microcirculation. The traditional use of the plant for vascular health aligns with several small clinical trials examining its effects on venous insufficiency.
Studies have shown that active constituents in Centella asiatica, particularly the triterpenes, may enhance collagen synthesis and stabilize connective tissue in blood vessel walls. Animal models suggest improved vascular tone and endothelial function. In humans, multiple short-term trials (typically 4–12 weeks) have reported improvements in subjective symptoms such as leg heaviness and swelling in people with chronic venous insufficiency. However, effect sizes are modest, and many trials are limited by small sample sizes, short duration, and lack of objective biomarkers beyond symptom questionnaires.
The evidence here is suggestive rather than compelling. A 2013 systematic review noted that while Centella asiatica shows promise for venous insufficiency, the quality of evidence remains “low to moderate,” and larger, well-controlled trials would be needed to establish clinical relevance in real-world populations.
Skin Health and Wound Healing
Traditionally, Gotu Kola has been applied topically for skin conditions and wound healing. This use is supported by both traditional practice and modern experimental data.
In vitro and animal studies demonstrate that Centella asiatica extracts promote collagen synthesis, increase angiogenesis (blood vessel formation), and reduce inflammatory markers. These mechanisms plausibly support wound healing and skin integrity. Some small human trials have examined topical or oral Gotu Kola in the context of minor cuts, surgical wounds, and general skin appearance, with mixed but generally positive results.
However, human evidence remains sparse and often confounded with other ingredients or formulations. Most published studies focus on specific skin conditions (e.g., cellulite, scars) or acute wound scenarios, and few offer clear dose–response relationships or long-term follow-up. The evidence is strongest for acute wound healing in clinical settings, but weaker for chronic skin health claims or aesthetic use in healthy individuals.
Cognitive and Mood Support
Recent interest in Gotu Kola has centered on potential cognitive benefits, particularly memory and attention. This interest stems partly from its traditional use as a mental tonic and partly from preliminary experimental and clinical data.
Several animal studies show that Centella asiatica extracts enhance cognition and protect neurons in models of cognitive decline. A small 2017 human trial by Puttarak et al. examined Centella asiatica in healthy volunteers and found some improvements in attention and mood-related measures, though effect sizes were modest and the sample was small. Other trials report improvements in memory or processing speed, but most are limited by small sample sizes, lack of placebo controls, or confounded interventions.
The mechanistic plausibility is there—triterpenes may reduce neuroinflammation and support synaptic function—but human data are preliminary. The evidence is sufficient to warrant further research but not sufficient to make strong clinical claims.
Safety Considerations
Gotu Kola is generally regarded as safe at typical supplemental doses (500–1000 mg daily). Adverse event rates in clinical trials are low and similar to placebo. However, case reports of hepatotoxicity and skin sensitization exist, particularly with long-term or high-dose use.
People with a history of liver disease, those taking hepatotoxic medications, or pregnant and nursing individuals should exercise caution and consult a healthcare provider. Liver function tests are a reasonable precaution for long-term users, particularly at doses above 1000 mg daily.
Regulatory Status and Claims
In the European Union, Gotu Kola is not approved for health claims under the EFSA Register of Nutrition and Health Claims. This means marketers cannot claim that Gotu Kola supports brain function, vascular health, or skin integrity in the EU market. This regulatory decision reflects the current evidence base: while plausible and supported by preliminary data, it is not robust enough to meet the EU’s stringent standard for authorizing claims.
This does not mean Gotu Kola is ineffective, merely that the evidence, while suggestive, falls short of regulatory approval thresholds.
Overall Assessment
Gotu Kola is an interesting herbal ingredient with plausible mechanisms, traditional historical use, and emerging modern research. It is likely safe at typical doses. However, the human evidence for cognitive, vascular, or skin benefits remains mixed and often limited by small sample sizes, short duration, and lack of rigorous outcome measures.
If you are considering Gotu Kola, realistic expectations are important: this is not a front-line intervention for any health domain, but rather a complementary botanical with modest supportive evidence and a good safety profile. It pairs well with lifestyle interventions (exercise, hydration, sleep) and may be worth exploring if marketed candidly and at a reasonable cost.